US Brand Name(s) for Inotuzumab Ozogamicin: Besponsa
Use in Cancer Treatment
Inotuzumab ozogamicin is authorized to treat the following conditions:
- Acute lymphoblastic leukemia of the B-cell type (ALL). It is used in people with relapsed or refractory illness (does not respond to treatment).
- This is also being researched for use in the treatment of various cancers.
Detailed scientific definition- Definition from the NCI Drug Dictionary –
Inotuzumab Ozogamicin – MedlinePlus Information A summary of key facts regarding this medication in layman’s terms, which may contain the following:
cautions about this medicine, what it’s used for and how it’s used, what you should tell your doctor before taking it, what you should know about it before using it, other drugs that might interact with it, and possible negative effects
Drugs are frequently investigated to see whether they can assist treat or prevent conditions other than those for which they have been authorised. Only authorised uses of the medication are covered by this patient information leaflet. Much of the material, though, might also apply to authorised uses that are being investigated.
